Givaudan | GIVN - Cash And Equivalent

Stock Price
2,810.00
Daily Change
-10.00 -0.35%
Monthly
4.00%
Yearly
-28.26%
Q2 Forecast
2,758.85

Givaudan reported CHF603M in Cash and Equivalent for its fiscal semester ending in June of 2024.





Cash And Equivalent Change Date
Air Liquide EUR 3.96B 2.05B Dec/2025
Akzo Nobel EUR 1.62B 66M Dec/2025
Anheuser-Busch USD 7.06B 4.11B Jun/2025
Arkema EUR 1.95B 642M Sep/2025
Associated British Foods GBP 1.06B 299M Jun/2025
BASF EUR 2.67B 811M Dec/2025
Bayer EUR 5.9B 1.34B Sep/2025
Beiersdorf EUR 1.2B 33M Dec/2025
British American Tobacco GBP 4.4B 1.53B Jun/2025
Covestro EUR 604M 115M Sep/2025
Croda International GBP 157.8M 9M Jun/2025
Danone EUR 1.98B 364M Dec/2025
Diageo GBP 2.2B 544M Jun/2025
Fresenius EUR 1.23B 1.16B Jun/2025
Fresenius Medical Care EUR 1.58B 326.57M Dec/2025
Givaudan CHF 603M 3M Jun/2024
Glanbia EUR 417M 116.1M Jan/2025
Heineken EUR 2.07B 284M Jun/2025
International Flavors Fragrances USD 590M 31M Dec/2025
Johnson Matthey GBP 542M 49M Jun/2024
Lonza CHF 719M 188M Dec/2025
L'Oréal EUR 9.86B 5.04B Dec/2025
Merck EUR 2.25B 1.08B Sep/2025
Nestle CHF 4.58B 73M Dec/2025
Pernod Ricard EUR 2.4B 569M Dec/2025
Reckitt Benckiser GBP 880M 106M Dec/2024
SGS CHF 1.21B 78M Dec/2024
Sika AG CHF 1.87B 1.18B Dec/2022
Solvay EUR 410M 77M Sep/2025
Tate & Lyle GBP 475M 41M Jun/2023
Umicore EUR 1.11B 903.9M Jun/2025
Victrex GBP 58.7M 13M Dec/2022